sotorasib plus panitumumab in kras-mutated colorectal cancer | nejm
Published 8 months ago • 2K plays • Length 2:17Download video MP4
Download video MP3
Similar videos
-
4:09
highlights on sotorasib plus panitumumab in kras g12c-mutated mcrc: the codebreak 300 study
-
12:04
sotorasib plus panitumumab in refractory kras g12c-mutated colorectal cancer
-
7:19
safety of sotorasib and panitumumab in advanced kras p.g12c-mutated colorectal cancer
-
3:11
sotorasib and panitumumab demonstrate clinically meaningful benefit in kras g12c-mutated metasta...
-
2:09
esmo highlights: kras g12c inhibitors
-
2:09
perioperative chemoimmunotherapy in lung cancer | nejm
-
2:29
sotorasib achieved clinically meaningful activity in kras g12c-mutated advanced pancreatic cancer
-
0:58
kras g12c inhibitors for gi cancer
-
2:55
codebreak 300: sotorasib panitumumab vs. standard-of-care in chemorefractory kras g12c mcrc
-
2:59
sotorasib outperforms docetaxel in previously treated kras-mutated nsclc | melissa johnson
-
1:42
treating kras g12c mutations
-
0:30
kras in the setting of colon cancer
-
6:28
codebreak 100: sotorasib in kras-mutated nsclc
-
2:42
codebreak 200: sotorasib versus docetaxel in pretreated kras g12c-mutant nsclc
-
5:26
asco 2021 lung recap: codebreak 100: sotorasib in kras g12c mutation
-
2:59
kras/nras and braf mutations in study of panitumumab plus folfiri for second-line treatment of mcc
-
4:46
we're finally beginning to crack the kras nut in colorectal cancer
-
2:35
#esmo22 highlights on sotorasib in nsclc with kras g12c mutation: the codebreak 200 study